These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 291948)

  • 21. [Use of a new interferon inducer and leukocyte interferon for a significant enhancement of the immunocytotherapy of leukemia in mice].
    Madzhidov AV; Poverennyĭ AM; Popov GA; Fuks BB
    Biull Eksp Biol Med; 1983 Jan; 95(1):63-5. PubMed ID: 6830962
    [No Abstract]   [Full Text] [Related]  

  • 22. Augmentation of mouse natural killer cell activity by interferon and interferon inducers.
    Djeu JY; Heinbaugh JA; Holden HT; Herberman RB
    J Immunol; 1979 Jan; 122(1):175-81. PubMed ID: 310826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple biological activities of homogeneous human alpha interferon.
    Attallah AM; Zoon K; Folks T; Huntington J; Yeatman TJ
    Infect Immun; 1981 Dec; 34(3):1068-70. PubMed ID: 6174447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effect of interferon on multiplication of Friend leukemia cells in vivo.
    Rossi GB; Marchegiani M; Matarese GP; Gresser I
    J Natl Cancer Inst; 1975 Apr; 54(4):993-6. PubMed ID: 1127730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of anti-RNA antibody-binding sites on the surfaces of Ehrlich ascites tumor cells.
    Terasaki T
    Cell Struct Funct; 1984 Jun; 9(2):181-5. PubMed ID: 6209022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition by interferon of thymidine uptake in chemostat cultures of L1210 cells.
    Brouty-Boyé D; Tovey MG
    Intervirology; 1978; 9(4):243-52. PubMed ID: 304053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiproliferative activity of highly purified mouse interferon: brief communication.
    Buffett RF; Ito M; Cairo AM; Carter WA
    J Natl Cancer Inst; 1978 Jan; 60(1):243-6. PubMed ID: 628021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Large scale production of mouse interferons from monolayers of Ehrlich ascites tumour cells.
    Taira H; Broeze RJ; Slattery E; Lengyel P
    J Gen Virol; 1980 Jul; 49(1):231-4. PubMed ID: 6158556
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of interferon and other lymphokines during murine tumour growth. II. Induction of an interferon by Ehrlich ascites cells in outbred mice.
    Lackovic V; Borecký L; Zschiesche W; Fahlbusch B; Schumann I
    Acta Virol; 1980 Jan; 24(1):45-54. PubMed ID: 6155777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of virus-induced interferon on the antibody response of suckling and adult mice.
    Vignaux F; Gresser I; Fridman WH
    Eur J Immunol; 1980 Oct; 10(10):767-72. PubMed ID: 6159214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of mouse natural killer cell activity by type II interferon.
    Senik A; Stefanos S; Kolb JP; Lucero M; Falcoff E
    Ann Immunol (Paris); 1980; 131C(3):349-61. PubMed ID: 6157349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiproliferative action of interferon on murine L1210 cells: interrelationship with prostaglandins.
    Brideau RJ; Stringfellow DA
    J Interferon Res; 1983; 3(4):409-15. PubMed ID: 6423736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition by interferon of delayed-type hypersensitivity in the mouse.
    De Maeyer E; De Maeyer-Guignard J; Vandeputte M
    Proc Natl Acad Sci U S A; 1975 May; 72(5):1753-7. PubMed ID: 168573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of proliferation of Ehrlich ascites carcinoma cells in vitro and in vivo by halogeno analogues of long chain acyl- and alkylglycerols.
    Langen P; Brachwitz H; Schildt J
    Acta Biol Med Ger; 1979; 38(7):965-74. PubMed ID: 543374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased susceptibility of cells treated with interferon to the toxicity of polyriboinosinic-polyribocytidylic acid.
    Stewart WE; De Clercq E; Billiau A; Desmyter J; De Somer P
    Proc Natl Acad Sci U S A; 1972 Jul; 69(7):1851-4. PubMed ID: 4505664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural killing in estrogen-treated mice responds poorly to poly I.C despite normal stimulation of circulating interferon.
    Seaman WE; Merigan TC; Talal N
    J Immunol; 1979 Dec; 123(6):2903-5. PubMed ID: 227961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of chemostat culture for the study of the effect of interferon on tumor cell multiplication.
    Tovey MG
    Methods Enzymol; 1981; 79(Pt B):391-404. PubMed ID: 6173686
    [No Abstract]   [Full Text] [Related]  

  • 38. Purification of highly radioactive mouse interferon produced by Ehrlich ascites tumour cells induced by Sendai virus.
    Dussaix E; Gregoire A; Chany C; Thang DC; Thang MN
    J Gen Virol; 1983 Feb; 64 (Pt 2)():285-90. PubMed ID: 6187892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antitumor effects of interferon (author's transl)].
    Nagata I
    Tanpakushitsu Kakusan Koso; 1976 Apr; 21(4):271-7. PubMed ID: 796877
    [No Abstract]   [Full Text] [Related]  

  • 40. Interferon enhances the expression of Fc gamma receptors.
    Fridman WH; Gresser I; Bandu MT; Aguet M; Neauport-Sautes C
    J Immunol; 1980 May; 124(5):2436-41. PubMed ID: 6154103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.